A chiral ionic liquid (IL), S-[3-(chloro-2-hydroxypropyl)trimethylammonium] [bis((trifluoromethyl)sulfonyl)amide]
(S-[CHTA](+)[Tf(2)N](-)), which can be easily and readily synthesized in a one-step
process from commercially available reagents, can be successfully used both as co-electrolyte
and as a chiral selector for CE. A variety of pharmaceutical products including atenolol,
propranolol, warfarin, indoprofen, ketoprofen, ibuprofen and flurbiprofen, can be
successfully and baseline separated with the use of this IL as electrolyte. Interestingly,
while S-[CHTA](+)[Tf(2)N](-) can also serve as a chiral selector, enantioseparation
cannot be successfully achieved with S-[CHTA](+)[Tf(2)N](-) as the only chiral selector.
In the case of ibuprofen, a second chiral selector, namely a chiral anion (sodium
cholate), is needed for the chiral separation. For furbiprofen, in addition to S-[CHTA](+)[Tf(2)N](-)
and sodium cholate, a third and neutral chiral selector, 1-S-octyl-beta-d-thioglucopyranoside
(OTG), is also needed. Due to the fact that the chirality of this chiral IL resides
on the cation (i.e., -[CHTA](+)), and that needed additional chiral selector(s) are
either chiral anion (i.e., cholate) or chiral neutral compound (OTG), the results
obtained seem to suggest that additional chiral selector(s) are needed to provide
the three-point interactions needed for chiral separations.